Axonics® reports first quarter 2021 financial results

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the first quarter ended march 31, 2021. “this quarter's revenue result reflects growing demand for our long-lived r-snm® system and bulkamid® despite the resurgence of covid cases in the u.s. in early 2021 and ongoing lockdowns in europe,” said raymond w. c
AXNX Ratings Summary
AXNX Quant Ranking